Dragonfly Therapeutics Announces Multi-Target Expansion of Its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases

0
289
Dragonfly Therapeutics, Inc. announced an expansion of its research collaboration with AbbVie to discover and develop Dragonfly’s novel immunotherapies for new targets in autoimmune and fibrotic diseases.
[Dragonfly Therapeutics, Inc.]
Press Release